4.2 Article

Evolutionary history of the SARS-CoV-2 Gamma variant of concern (P.1): a perfect storm

Journal

GENETICS AND MOLECULAR BIOLOGY
Volume 45, Issue 1, Pages -

Publisher

SOC BRASIL GENETICA
DOI: 10.1590/1678-4685-GMB-2021-0309

Keywords

Gamma; P.1; evolution; COVID-19

Funding

  1. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]
  2. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
  3. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
  4. Instituto de Pesquisa do Cancer de Guarapuava

Ask authors/readers for more resources

This study aimed to provide a detailed description of the evolutionary history of Gamma and its derived lineages (P.1.1 and P.1.2). Positive selection sites were detected in P.1.1 and P.1.2, with an exclusive haplotype in P.1.2 originating from a non-synonymous mutational step. Phenomena such as epistasis and antagonistic pleiotropy may limit the emergence of new alleles in SARS-COV-2 lineages.
Our goal was to describe in more detail the evolutionary history of Gamma and two derived lineages (P.1.1 and P.1.2), which are part of the arms race that SARS-CoV-2 wages with its host. A total of 4,977 sequences of the Gamma strain of SARS-CoV-2 from Brazil were analyzed. We detected 194 sites under positive selection in 12 genes/ORFs: Spike, N, M, E, ORF1a, ORF1b, ORF3, ORF6, ORF7a, ORF7b, ORF8, and ORF10. Some diagnostic sites for Gamma lacked a signature of positive selection in our study, but these were not fixed, apparently escaping the action of purifying selection. Our network analyses revealed branches leading to expanding haplotypes with sites under selection only detected when P.1.1 and P.1.2 were considered. The P.1.2 exclusive haplotype H_5 originated from a non-synonymous mutational step (H3509Y) in H_1 of ORF1a. The selected allele, 3509Y, represents an adaptive novelty involving ORF1a of P.1. Finally, we discuss how phenomena such as epistasis and antagonistic pleiotropy could limit the emergence of new alleles (and combinations thereof) in SARS-COV-2 lineages, maintaining infectivity in humans, while providing rapid response capabilities to face the arms race triggered by host immuneresponses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available